Eli Lilly And Company

Organisation

Lilly Corporate Center, Indianapolis, IN, United States, 46285

Headquarters

50000

Employees

Health Technology

Industry

David Ricks

Lilly (Eli) & Co. is an American-based multinational pharma company with offices in 18 countries. Its headquarters are situated in Indianapolis, Indiana, and it sells drugs in over 125 countries. Colonel Eli Lilly was a pharmaceutical chemist and American Civil War veteran who founded this company in 1876. It is traded as LLY in the New York Stock Exchange (NYSE).
Lilly employs over 33,000 people and generated a revenue of over 22 billion USD as of 2019. The company is committed to researching and developing high-quality drugs for humankind's welfare by remaining true to its work.
In 1876, this company produced the medicinal drug called quinine used in the treatment of Malaria. Among its many commendable innovations were gelatin-coating for the capsules & pills and sugar-coated pills that make them easier to swallow. It also developed various drugs for treating syphilis, rheumatism, eczema, and psoriasis in the early 1880s.
A scientific journal asserted that the Lilly operation was the largest capsule factory in the world in 1917. In 1923, Lilly mass-produced the Insulin under the name “Iletin” used to treat diabetes in the US. Moreover, it also became the company to mass-produce Penicillin in the 1940s and started producing the Polio vaccine in the early 1950s. It acquired CoLucid in 20017 for 960mn USD and Armo Biosciences for 1.6bn USD in 2018. Also, it purchased the Aurora Kinase A, an inhibitor developer, for 575mn USD.
It acquired multiple companies for developing and researching breakthroughs. The company aims to bring life-changing research to the community while performing voluntary & philanthropist operations worldwide.
Currently Eli Lilly And Company has a market cap of $893.59 Billion. It has a P.E ratio of 121.71. The shares of Eli Lilly And Company are trading at $935.58.
 .

Price

Target

Eli Lilly And Company (LLY) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Eli Lilly And Company (LLY) share price will touch around $1209.21 in next 12-months.

Currently 32 wall-street analysts regularly analyze the financials of Eli Lilly And Company on a frequent basis to provide recommendations along with target share price. 32 analysts offering 12-month price forecasts for Eli Lilly And Company (LLY) have a share price target of $1209.21. This median of share price forecast represents a 29.23% upside from the latest price of $935.73 as on 05.04.26.

Eli Lilly And Company (LLY) Share Price Forecast

Home

US Stocks

Eli Lilly And Company (LLY)

Eli Lilly And Company Stock Forecast

Eli Lilly And Company Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Eli Lilly And Company (LLY): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Eli Lilly And Company's share price and its median forecast price. As on 05.04.26, the difference is -21.06%

Eli Lilly And Company Forecast and Target Price

Eli Lilly And Company (LLY) Share Price Forecast

Eli Lilly And Company (LLY) Price vs Consensus Price Target

Eli Lilly And Company (LLY) Share Price Forecast v/s Share Price Today

Eli Lilly And Company (LLY): Difference between Current Price & Median Forecasted Price

Eli Lilly And Company (LLY) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price